July 26 (Reuters) - Germany's Merck (MRCG.DE) on Friday raised its forecast for the group, mainly driven by a strong operating performance at its healthcare and electronics units.

In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries. The company holds the global rights to the name and trademark “Merck” internationally.

In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries. The company holds the global rights to the name and trademark “Merck” internationally.

By Ankur Banerjee SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent ...

As of December 31, 2024, Merck Germany had cash and cash equivalents of 2.52 billion euros.

Germany's Merck KGaA said it will buy Unity-SC in a deal worth 155 million euros ($169.6 million) plus further performance-based payments, as it seeks to expand its offering for artificial ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

Germany's Merck also predicted a turning point early during the second half of 2024 for chemicals used in semiconductor manufacturing, where it is among the world's largest suppliers.

NEW YORK/FRANKFURT (Reuters) - Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion to add rare cancer therapies ahead of ...